The Chemours Company Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-305	-386	69	-252	578	608
Depreciation & Amortization	319	340	309	292	291	317
Stock-Based Compensation	23	21	15	18	27	34
Other Adjustments	-6	172	-156	-31	-26	-166
Change in Receivables	62	106	-139	-14	91	-225
Changes in Inventories	50	-106	-140	61	-294	-210
Changes in Accounts Payable	-90	-165	4	-74	105	281
Changes in Accrued Expenses	131	-3	-660	642	-47	97
Changes in Other Operating Activities	218	346	-87	3	42	78
Operating Cash Flow	397	264	-633	556	755	814
Operating Cash Flow Growth	53.88%	-	-	-26.36%	-7.25%	0.87%
Capital Expenditures	-179	-213	-360	-370	-307	-277
Sale of Property, Plant & Equipment	300	7	3	143	33	508
Other Investing Activities	-5	0	4	-2	-10	-11
Investing Cash Flow	117	-206	-353	-229	-284	220
Long-Term Debt Issued	2,053	748	606	648	-	650
Long-Term Debt Repaid	-1,645	-787	-490	-280	-68	-872
Net Long-Term Debt Issued (Repaid)	408	-39	116	368	-68	-222
Issuance of Common Stock	3	9	1	19	51	23
Repurchase of Common Stock	-2	-1	-3	-88	-501	-175
Net Common Stock Issued (Repurchased)	1	8	-2	-69	-450	-152
Common Dividends Paid	-54	-78	-148	-149	-154	-164
Other Financing Activities	-26	-9	-29	42	-14	-16
Financing Cash Flow	-350	-126	-36	172	-686	-554
Foreign Exchange Rate Adjustments	6	29	-22	4	-32	-34
Net Cash Flow	170	-39	-1,044	503	-247	446
Free Cash Flow	218	51	-993	186	448	537
Free Cash Flow Growth	-	-	-	-58.48%	-16.57%	-0.56%
FCF Margin	3.76%	0.88%	-17.17%	3.06%	6.56%	8.46%
Free Cash Flow Per Share	1.44	0.34	-6.61	1.25	2.83	3.18
Levered Free Cash Flow	553	-226	-749	669	300	672
Unlevered Free Cash Flow	-782.39	109.82	-726.35	359.85	392.18	894

SEC Filings: 10-K · 10-Q